Cataract Clinical Trial
Official title:
Clinical Study - ES 900 - 2020-1
EYESTAR 900 is a device developed by Haag-Streit which utilises 3D OCT for quantitative measurements of the geometry of the entire eye, including ocular biometry and corneal topography. It is the most recent in a series of successful biometry devices by Haag-Streit (HS Pachymeter, Lenstar LS 900, LS 900 T-cone and LS 900 APS) and also allows for advanced corneal tomography examinations. The EYESTAR 900 is CE marked. These measurement results of this device are used for the planning of the medical treatment of patients. Depending on the application, the benefits of this device may include improved visual acuity (after cataract surgery), reduced risk of complications (after refractive surgery or implant of a phakic intraocular lens), early identification of pathological deformations of the cornea (keratoconus detection). The primary objective of this clinical trial is to assess the clinical performance of the investigational device in dense cataracts. To that end, for each measurand, the in-vivo repeatability will be quantified, as well as limits of agreement and the mean measurement deviation, with respect to the current gold standard device. As a secondary objective of the study, raw measurement data will be collected to allow for the improvement of existing algorithms, development of additional measurands and for retrospective analysis. No diseases are studied.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | February 28, 2024 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years and older |
Eligibility | Inclusion Criteria: - voluntary participation - informed consent - 35 years of age or older Exclusion Criteria: - ineligibility for cataract surgery for any reason, e.g., aphakia - Disqualifying pathologies: - keratoconus - corneal astigmatism of more than 3.5 D - history of recurrent inflammation or infection of the eye - Disqualifying corneal conditions: - comorbidities, - deformations, - lesions, or - scarring of the cornea - acute inflammation or infection of the eye - Disqualifying treatments: - previous refractive surgeries, including PRK and LASIK - previous corneal surgeries - previous corneal transplants - previous intraocular surgeries - Disqualifying outcomes: - failed IOL implantation into the capsular bag |
Country | Name | City | State |
---|---|---|---|
India | Aravind Eye Hospitals | Chennai | Tamil Nadu |
Lead Sponsor | Collaborator |
---|---|
Haag-Streit AG | Aravind Eye Hospitals, India |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dense Cataract Performance | The primary outcome is the performance of the EYESTAR 900 in dense cataracts. Specifically, the highest grade of cataract at which complete measurements can reliably be performed and, consequently, the number of patients measured successfully. | 18 months | |
Secondary | Keratometry | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Axial Length | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | White-to-White Imaging | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Anterior Corneal Elevation | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Anterior Corneal Axial Curvature | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Anterior Corneal Tangential Curvature | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Posterior Corneal Elevation | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Posterior Corneal Axial Curvature | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Posterior Corneal Tangential Curvature | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Corneal Pachymetry | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Simulated Anterior Keratometry | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months | |
Secondary | Simulated Posterior Keratometry | The limits of agreement and the confidence interval of difference in comparison with the LENSTAR 900. | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |